Home

Relevant info

Agenda

"Building Bridges Around Building Genomes"
Synthetic Genomics Workshop
August 4-5, 2009
Intercontinental Mark Hopkins, San Francisco, CA

Download pdf

Day 1
8:00 AMRegistration
9:00 AMOpening Remarks
Peacock Court (all day)

Section Chief Joseph Campbell
Federal Bureau of Investigation
Weapons of Mass Destruction Directorate

Special Agent in Charge Stephanie Douglas
FBI San Francisco Field Office

Carol Linden, Ph.D.
Principal Deputy Director
Biomedical Advanced Research and Development Authority
Department of Health and Human Services

Norman Neureiter, Ph.D
Director
Center for Science, Technology, and Security Policy
American Association for the Advancement of Science
9:15 AMPerspective: Current National Security Threat and Role of FBI

Assistant Section Chief Jeffrey Muller

FBI WMD Directorate
9:45 AMBroad View of Bio Security

Gerald Epstein, Ph.D.
Independent Science and Security Analyst
10:15 AM Break
10:30 AM Panel 1:Synthetic Biology: A Transforming Technology
Moderator:
Dana Perkins, Ph.D.,
Senior Science Advisor
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services

A: Current State of the Art/General Uses
Michele Garfinkel, Ph.D.
Policy Analyst and Associate Professor
J. Craig Venter Institute

B: Industry Perspective of Synthetic Biology
Drew Endy, Ph.D., Assistant Professor
Department of Bioengineering, Stanford University

C: The International Genetically Engineered Machine Competition
Randy Rettberg, Ph.D.
Director of the Registry of Standard Biological Parts
Director of iGEM
Principal Research Engineer in Biological Engineering,
Massachusetts Institute of Technology

D: An Emerging Challenge
Lawrence Kerr, Ph.D.
National Counterproliferation Center,
Office of the Director of National Intelligence
11:45 PM Lunch
1:00 PM Framing the US Priorities: History and Approach

Michael Imperiale, Ph.D.
NSABB Member
Arthur F. Thurnau Professor of Microbiology and Immunology University of Michigan

Jessica Tucker, Ph.D.
AAAS Science and Technology Policy Fellow
Office of the Assistant Secretary for Preparedness and Response Department of Health and Human Services
1:30 PMPanel 2: Mitigating the Potential Risks and Building a Culture of Responsibility, Trust, and Cooperation between the Scientific and Security Communities on Synthetic Genomics

Moderator:
Kavita Berger, Ph.D.
Project Director
Center for Science, Technology and Security Policy
American Association for the Advancement of Science

A: Ethical and Legal Implementation
Michael Selgelid, Ph.D.
Senior Research Fellow
Centre for Applied Philosophy and Public Ethics [CAPPE] Deputy Director, National Centre for Biosecurity
The Australian National University, Canberra

B: Homeland Security
Sara Klucking, Ph.D.
Senior Scientist
Threat Characterization and Attribution, Chemical and Biological Division, Science and Technology Directorate
Department of Homeland Security

C: Research Community
Carrie Wolinetz, Ph.D.
President, Director of Communications, Office of Public Affairs
Federation of American Societies for Experimental Biology

Short Break

Panel 2: Mitigating the Potential Risks and Building a Culture of Responsibility, Trust, and Cooperation between the Scientific and Security Communities on Synthetic Genomics
(continued)

D: Synthetic Genomics Company
John Mulligan, Ph.D.
Chairman/Chief Scientific Officer
Blue Heron Biotechnology

E: Do It Yourself Biology
Jason Bobe, B.A., MSIS
Director of Community, Personal Genome Project
Harvard Medical School
Do- It- Yourself Biology [DIYbio]

F: Law Enforcement
Edward You
Supervisory Special Agent
Weapons of Mass Destruction Directorate
Countermeasures and Preparedness Section
Bioterrorism Program
Federal Bureau of Investigation

3:30 PM General Discussion
4:30 PM Reception (Cash Bar)
Top of the Mark

Day 2
9:00 AM Recap of Day 1 Activities
Peacock Court
9:30 AMTable Top Exercise
Breakouts: California, Florentine, Garden, Powell
11:30 AMLunch
12:30 PMTable Top Exercise Review
1:00 PMPanel 3: International Perspectives
Peacock Court

Moderator:

Jessica Petrillo, Ph.D.
Bureau of International Security and Nonproliferation
Office of Chemical and Biological Weapons Reduction (ISN/CB)
U.S. Department of State

A: Corporate Global Perspective
Gary Burns, Ph.D.
Biosafety Officer
AstraZeneca
United Kingdom

B: Foreign Approaches to Pathogen Security
Jeremey Littlewood, Ph.D.
Director
Canadian Centre of Intelligence and Security Studies
Carleton University, Ottawa, Canada

C: International Association of Synthetic Biology (IASB)
Cord Staehler, Ph.D.
President/Chief Executive Officer
Febit Biomed gmbh, Germany

Break

D: Domestic and International Industry Efforts
Claes Gustafsson, PhD.
VP Sales and Marketing
DNA2.0 Inc

E: Federal Law Enforcement Perspective
Paul Roffey, Ph.D.
Forensic Microbiologist
Forensic and Data Centres
Australian Federal Police

F: UN Biological Weapons Convention Perspective
Piers Millet, Ph.D.
Biological Weapons Convention
Implementation Support Unit
Office for Disarmament Affairs
United Nations

3:00 PMGeneral discussion
Peacock Court
4:30 PMConference Conclusion